Baker Bros. Advisors’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-166,619
Closed -$6.35M 118
2022
Q3
$6.35M Sell
166,619
-34,825
-17% -$1.75M 0.04% 70
2022
Q2
$11M Hold
201,444
0.06% 59
2022
Q1
$12.6M Hold
201,444
0.07% 59
2021
Q4
$20.3M Sell
201,444
-199,572
-50% -$17.5M 0.1% 59
2021
Q3
$36.1M Hold
401,016
0.16% 47
2021
Q2
$37M Hold
401,016
0.16% 46
2021
Q1
$38.7M Sell
401,016
-94,557
-19% -$9.76M 0.17% 49
2020
Q4
$25.8M Sell
495,573
-50,616
-9% -$2.12M 0.1% 52
2020
Q3
$21.9M Sell
546,189
-23,255
-4% -$728K 0.09% 51
2020
Q2
$9.11M Hold
569,444
0.04% 64
2020
Q1
$6.13M Hold
569,444
0.04% 59
2019
Q4
$7.35M Buy
569,444
+444,444
+356% +$5.28M 0.04% 61
2019
Q3
$1.3M Hold
125,000
0.01% 94
2019
Q2
$835K Hold
125,000
0.01% 97
2019
Q1
$744K Hold
125,000
﹤0.01% 91
2018
Q4
$396K Hold
125,000
﹤0.01% 91
2018
Q3
$491K Hold
125,000
﹤0.01% 97
2018
Q2
$518K Hold
125,000
﹤0.01% 115
2018
Q1
$500K Hold
125,000
﹤0.01% 110
2017
Q4
$548K Hold
125,000
﹤0.01% 115
2017
Q3
$599K Hold
125,000
﹤0.01% 112
2017
Q2
$799K Hold
125,000
0.01% 106
2017
Q1
$1.36M Hold
125,000
0.01% 96
2016
Q4
$1.45M Hold
125,000
0.01% 100
2016
Q3
$1.15M Buy
+125,000
New +$1.15M 0.01% 107

Other funds holding FLGT

Baker Bros. Advisors's FLGT Position: Q4 2022 in Review

Baker Bros. Advisors sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 166,619 shares — an estimated $6.35M sold.

Baker Bros. Advisors first reported a position in FLGT in Q3 2016 and held it in 25 quarters. The position peaked at $38.7M in Q1 2021. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

  • Baker Bros. Advisors reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
  • Baker Bros. Advisors sold 166,619 Fulgent Genetics shares in Q4 2022, an estimated $6.35M.
  • Baker Bros. Advisors first reported a position in Fulgent Genetics in Q3 2016 and held it in 25 quarters.
  • Baker Bros. Advisors's Fulgent Genetics position peaked at $38.7M in Q1 2021.
  • 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on Baker Bros. Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.